Fatigue News and Research

RSS

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB today announced data that showed rapid and sustained improvements in ACR20, physical function, pain and fatigue of rheumatoid arthritis (RA) as early as the first week, and inhibition of progression of structural joint damage (seen at week 24) following treatment with Cimzia (certolizumab pegol), together with methotrexate (MTX), was sustained up to 100 weeks.

19 Oct 2009

California's community hospitals launch public education and media campaign on H1N1

As preparations for the H1N1 flu season kick into high gear, California's community hospitals have launched a statewide public education and media campaign.

19 Oct 2009

FDA approves GlaxoSmithKline Biologicals' Cervarix for prevention of cervical cancer

The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.

19 Oct 2009

Campaign to educate men and women about fibromyalgia

Women and men have opposing views on many topics, and it turns out that they also have different takes on chronic pain.

19 Oct 2009

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).

19 Oct 2009

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

19 Oct 2009

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

19 Oct 2009

First Priority implements Global Vision's automated inspection solutions

During tough economic times, First Priority, manufacturer of generic veterinary pharmaceutical products, implemented Global Vision's automated inspection solutions in an effort to reduce costs without compromising efficiencies and quality of their products.

15 Oct 2009

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

A new survey of 2,001 adults living with depression revealed that despite being diagnosed for an average of 12 years, many unknowingly took actions that could have sabotaged their chances of getting well. Furthermore, on average, it took about six years for respondents to seek diagnosis from a health care professional, suggesting these adults may have been coping with depression for as long as 18 years.

15 Oct 2009

Control and coordination may aid multiple sclerosis patients perform daily activities independently

While gripping, lifting or manipulating an object such as drinking from a cup or placing a book on a shelf is usually easy for most, it can be challenging for those with neurological diseases such as multiple sclerosis or Parkinson's, or for people who had a stroke.

15 Oct 2009

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

ZIOPHARM Oncology, Inc. announced today positive top line interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The analysis evaluated 62 patients treated as of the end of September, with 58 being analyzed.

14 Oct 2009

Physicians having less than six hours of sleep linked to increase rate of surgical complications

Attending surgeons and obstetricians/gynecologists who worked nighttime hours did not have a significantly greater rate of complications for procedures performed the next day, but having less than six hours of opportunity for sleep between procedures was associated with an increased rate of surgical complications, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

PhysioNetics receives grant to continue development of 'gripper' for upper-extremity prostheses

A $750,000 Phase II grant from the National Institutes of Health will allow PhysioNetics, LLC to continue its development work on an innovative new “gripper” for upper-extremity prostheses.

13 Oct 2009

Opinion: Improving U.S. foreign assistance; revisiting U.S. food aid

"Bureaucratic sprawl has sapped the strength of many of [U.S.] aid programs. Our government's global development policies and programs are scattered across 12 departments, 25 different agencies and nearly 60 government offices. The organization chart looks like a haystack, and it needs new, clear lines of responsibility," Charles Raynal, a professor at Columbia Theological Seminary, writes in an Atlanta Journal-Constitution opinion piece.

12 Oct 2009

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Pfizer Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-naïve adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.

9 Oct 2009

Muscle Flex develops a strong portfolio of 'Water' related products to maintain healthy lifestyle

Muscle Flex Inc. (www.MuscleFlexInc.com) announced today that it is developing a strong portfolio of "Water" related products to market using its direct response, online ecommerce and traditional retail methods. Muscle Flex® regards "Water" as potentially the most important ingredient in maintaining a healthy lifestyle and it is estimated that as much as 75% of Americans do not drink enough good clean water.

8 Oct 2009

Joslin Diabetes Center and Diabetica Research Solutions join to raise diabetes awareness

Joslin Diabetes Center (Joslin), the world-renowned leader in diabetes research and clinical care, and Diabetica Research Solutions, Inc. (DRSI), makers of drsi™ ReStore! Energy, the only energy and hydration formula specifically designed for the needs of people with diabetes, today announced they will work together to support diabetes causes and programs to which they are deeply committed, and help to educate others and raise awareness about diabetes, its causes and solutions, throughout the world.

8 Oct 2009

Brain injuries in Ontario's construction industry are highest in August and October

August may be the cruellest month for brain injuries in Ontario's construction industry, but a new study shows October is not far behind.

7 Oct 2009

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Nearly all patients who underwent surgery to treat oropharyngeal cancer experienced some degree of obstructive sleep apnea (OSA), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

7 Oct 2009

Fatigue News and Research

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

California's community hospitals launch public education and media campaign on H1N1

FDA approves GlaxoSmithKline Biologicals' Cervarix for prevention of cervical cancer

Campaign to educate men and women about fibromyalgia

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

First Priority implements Global Vision's automated inspection solutions

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

Control and coordination may aid multiple sclerosis patients perform daily activities independently

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

Physicians having less than six hours of sleep linked to increase rate of surgical complications

PhysioNetics receives grant to continue development of 'gripper' for upper-extremity prostheses

Opinion: Improving U.S. foreign assistance; revisiting U.S. food aid

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Muscle Flex develops a strong portfolio of 'Water' related products to maintain healthy lifestyle

Joslin Diabetes Center and Diabetica Research Solutions join to raise diabetes awareness

Brain injuries in Ontario's construction industry are highest in August and October

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News